<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Ginkgo extract EGb761 has shown anti-<z:hpo ids='HP_0000969'>edema</z:hpo> and anti-ischemic effects in various experimental models </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we demonstrate neuroprotective effects of EGb761 in experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> while monitoring brain metabolism by microdialysis </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We have used oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation in brain slices in vitro and middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) in vivo to induce <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in mouse brain </plain></SENT>
<SENT sid="3" pm="."><plain>We used microdialysis in mouse striatum to monitor extracellular concentrations of <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In vitro, EGb761 reduced <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced cell swelling in hippocampal slices by 60% </plain></SENT>
<SENT sid="5" pm="."><plain>In vivo, administration of EGb761 (300 mg/kg) reduced cell degeneration and <z:hpo ids='HP_0000969'>edema</z:hpo> formation after MCAO by 35-50% </plain></SENT>
<SENT sid="6" pm="."><plain>Immediately following MCAO, striatal <z:chebi fb="105" ids="17234">glucose</z:chebi> levels dropped to 25% of controls, and this reduction was not significantly affected by EGb761 </plain></SENT>
<SENT sid="7" pm="."><plain>Striatal <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> levels, in contrast, increased 15-fold after MCAO; after pretreatment with EGb761, <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> levels only increased by 4-5fold </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: We show that pretreatment with EGb761 strongly reduces cellular <z:hpo ids='HP_0000969'>edema</z:hpo> formation and <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> under conditions of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The mechanism of action seems to be related to a reduction of excitotoxicity, because <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced release of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> was strongly suppressed </plain></SENT>
<SENT sid="10" pm="."><plain>Ginkgo extracts such as EGb761 may be valuable to prevent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced damage in <z:hpo ids='HP_0001297'>stroke</z:hpo>-prone patients </plain></SENT>
</text></document>